Heterozygous defects in PAX6 gene and congenital hypopituitarism

• Published in: European journal of endocrinology Vol. 172; no. 1; pp. 37 - 45
• Main Authors: Takagi, Masaki, Nagasaki, Keisuke, Fujiwara, Ikuma, Ishii, Tomohiro, Amano, Naoko, Asakura, Yumi, Muroya, Koji, Hasegawa, Yukihiro, Adachi, Masanori, Hasegawa, Tomonobu
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01.01.2015
• Subjects: Adolescent; Adult; Child; Child, Preschool; Clinical Study; Crystallization; Eye Proteins - genetics; Female; Heterozygote; Homeodomain Proteins - genetics; Humans; Hypopituitarism - diagnosis; Hypopituitarism - genetics; Male; Paired Box Transcription Factors - genetics; PAX6 Transcription Factor; Pedigree; Repressor Proteins - genetics; Young Adult
• ISSN: 0804-4643; 1479-683X; 1479-683X
• DOI: 10.1530/EJE-14-0255

BackgroundThe prevalence of congenital hypopituitarism (CH) attributable to known transcription factor mutations appears to be rare and other causative genes for CH remain to be identified. Due to the sporadic occurrence of CH, de novo chromosomal rearrangements could be one of the molecular mechanisms participating in its etiology, especially in syndromic cases.ObjectiveTo identify the role of copy number variations (CNVs) in the etiology of CH and to identify novel genes implicated in CH.Subjects and methodsWe enrolled 88 (syndromic: 30; non-syndromic: 58) Japanese CH patients. We performed an array comparative genomic hybridization screening in the 30 syndromic CH patients. For all the 88 patients, we analyzed PAX6 by PCR-based sequencing.ResultsWe identified one heterozygous 310-kb deletion of the PAX6 enhancer region in one patient showing isolated GH deficiency (IGHD), cleft palate, and optic disc cupping. We also identified one heterozygous 6.5-Mb deletion encompassing OTX2 in a patient with bilateral anophthalmia and multiple pituitary hormone deficiency. We identified a novel PAX6 mutation, namely p.N116S in one non-syndromic CH patient showing IGHD. The p.N116S PAX6 was associated with an impairment of the transactivation capacities of the PAX6-binding elements.ConclusionsThis study showed that heterozygous PAX6 mutations are associated with CH patients. PAX6 mutations may be associated with diverse clinical features ranging from severely impaired ocular and pituitary development to apparently normal phenotype. Overall, this study identified causative CNVs with a possible role in the etiology of CH in <10% of syndromic CH patients.